News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Akron Biotechnology, LLC Awarded SBIR Grant For Development Of Novel Method To Isolate Adipose Derived Stem Cells


4/14/2014 9:39:31 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BOCA RATON, Fla.--(BUSINESS WIRE)--Akron Biotech, an innovative biotech company focused on serving the growing demands of the cell therapy industry, is pleased to announce it was awarded a Phase 1 Small Business Innovative Research (SBIR) Award from the National Institutes of Health (NIH) to develop enzyme-based formulations for the isolation of stem cells from various tissues. The project is in collaboration with Dr. Gregg Fields, Vice President of Scientific Affairs at Torrey Pines Institute for Molecular Studies, and will involve the use of novel engineered enzyme formulations to improve viability and quality of isolated stem cells with no toxicities.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES